157 related articles for article (PubMed ID: 36436093)
1. Prostaglandin E2 receptor EP1 expression in vulvar cancer.
Buchholz A; Vattai A; Fürst S; Vilsmaier T; Zati Zehni A; Steger A; Kuhn C; Schmoeckel E; Dannecker C; Mahner S; Jeschke U; Heidegger HH
J Cancer Res Clin Oncol; 2023 Jul; 149(8):5369-5376. PubMed ID: 36436093
[TBL] [Abstract][Full Text] [Related]
2. Prostaglandin E2 upregulates β1 integrin expression via the E prostanoid 1 receptor/nuclear factor κ-light-chain-enhancer of activated B cells pathway in non-small-cell lung cancer cells.
Bai X; Yang Q; Shu W; Wang J; Zhang L; Ma J; Xia S; Zhang M; Cheng S; Wang Y; Leng J
Mol Med Rep; 2014 May; 9(5):1729-36. PubMed ID: 24584670
[TBL] [Abstract][Full Text] [Related]
3. The EP1 receptor for prostaglandin E2 promotes the development and progression of malignant murine skin tumors.
Surh I; Rundhaug JE; Pavone A; Mikulec C; Abel E; Simper M; Fischer SM
Mol Carcinog; 2012 Jul; 51(7):553-64. PubMed ID: 21739481
[TBL] [Abstract][Full Text] [Related]
4. Cyclooxygenase-2-derived prostaglandin E2 promotes human cholangiocarcinoma cell growth and invasion through EP1 receptor-mediated activation of the epidermal growth factor receptor and Akt.
Han C; Wu T
J Biol Chem; 2005 Jun; 280(25):24053-63. PubMed ID: 15855163
[TBL] [Abstract][Full Text] [Related]
5. Upregulation of the EP1 receptor for prostaglandin E2 promotes skin tumor progression.
Surh I; Rundhaug J; Pavone A; Mikulec C; Abel E; Fischer SM
Mol Carcinog; 2011 Jun; 50(6):458-68. PubMed ID: 21268127
[TBL] [Abstract][Full Text] [Related]
6. Cyclooxygenase-2 expression is associated with initiation of hepatocellular carcinoma, while prostaglandin receptor-1 expression predicts survival.
Yang HJ; Jiang JH; Yang YT; Yang XD; Guo Z; Qi YP; Zeng FH; Zhang KL; Chen NZ; Xiang BD; Li LQ
World J Gastroenterol; 2016 Oct; 22(39):8798-8805. PubMed ID: 27818595
[TBL] [Abstract][Full Text] [Related]
7. Prostanoid receptor EP1 expression in breast cancer.
Thorat MA; Morimiya A; Mehrotra S; Konger R; Badve SS
Mod Pathol; 2008 Jan; 21(1):15-21. PubMed ID: 17906615
[TBL] [Abstract][Full Text] [Related]
8. Prostaglandin E2 EP1 receptor enhances TGF-β1-induced mesangial cell injury.
Chen X; Jiang D; Wang J; Chen X; Xu X; Xi P; Fan Y; Zhang X; Guan Y
Int J Mol Med; 2015 Jan; 35(1):285-93. PubMed ID: 25352206
[TBL] [Abstract][Full Text] [Related]
9. Prostaglandin E2 stimulates β1-integrin expression in hepatocellular carcinoma through the EP1 receptor/PKC/NF-κB pathway.
Bai X; Wang J; Guo Y; Pan J; Yang Q; Zhang M; Li H; Zhang L; Ma J; Shi F; Shu W; Wang Y; Leng J
Sci Rep; 2014 Oct; 4():6538. PubMed ID: 25289898
[TBL] [Abstract][Full Text] [Related]
10. Prostaglandin E2 activates the mTORC1 pathway through an EP4/cAMP/PKA- and EP1/Ca2+-mediated mechanism in the human pancreatic carcinoma cell line PANC-1.
Chang HH; Young SH; Sinnett-Smith J; Chou CE; Moro A; Hertzer KM; Hines OJ; Rozengurt E; Eibl G
Am J Physiol Cell Physiol; 2015 Nov; 309(10):C639-49. PubMed ID: 26310818
[TBL] [Abstract][Full Text] [Related]
11. EP3 (prostaglandin E2 receptor 3) expression is a prognostic factor for progression-free and overall survival in sporadic breast cancer.
Semmlinger A; von Schoenfeldt V; Wolf V; Meuter A; Kolben TM; Kolben T; Zeder-Goess C; Weis F; Gallwas J; Wuerstlein R; Hermelink K; Schmoeckel E; Harbeck N; Mayr D; Mahner S; Jeschke U; Ditsch N
BMC Cancer; 2018 Apr; 18(1):431. PubMed ID: 29661238
[TBL] [Abstract][Full Text] [Related]
12. Apigenin inhibits COX-2, PGE2, and EP1 and also initiates terminal differentiation in the epidermis of tumor bearing mice.
Kiraly AJ; Soliman E; Jenkins A; Van Dross RT
Prostaglandins Leukot Essent Fatty Acids; 2016 Jan; 104():44-53. PubMed ID: 26802941
[TBL] [Abstract][Full Text] [Related]
13. Direct growth-inhibitory effects of prostaglandin E2 in pancreatic cancer cells in vitro through an EP4/PKA-mediated mechanism.
Schmidt A; Sinnett-Smith J; Young S; Chang HH; Hines OJ; Dawson DW; Rozengurt E; Eibl G
Surgery; 2017 Jun; 161(6):1570-1578. PubMed ID: 28222855
[TBL] [Abstract][Full Text] [Related]
14. Prostaglandin E2 increases proximal tubule fluid reabsorption, and modulates cultured proximal tubule cell responses via EP1 and EP4 receptors.
Nasrallah R; Hassouneh R; Zimpelmann J; Karam AJ; Thibodeau JF; Burger D; Burns KD; Kennedy CR; Hébert RL
Lab Invest; 2015 Sep; 95(9):1044-55. PubMed ID: 26121313
[TBL] [Abstract][Full Text] [Related]
15. Activation of calcitonin gene-related peptide signaling through the prostaglandin E2-EP1/EP2/EP4 receptor pathway in synovium of knee osteoarthritis patients.
Minatani A; Uchida K; Inoue G; Takano S; Aikawa J; Miyagi M; Fujimaki H; Iwase D; Onuma K; Matsumoto T; Takaso M
J Orthop Surg Res; 2016 Oct; 11(1):117. PubMed ID: 27751171
[TBL] [Abstract][Full Text] [Related]
16. Prostaglandin E2 receptor EP1 phosphorylate CREB and mediates MMP2 expression in human cholangiocarcinoma cells.
Sun B; Rong R; Jiang H; Zhang H; Wang Y; Bai X; Zhang M; Ma J; Xia S; Shu W; Zhang L; Leng J
Mol Cell Biochem; 2013 Jun; 378(1-2):195-203. PubMed ID: 23494562
[TBL] [Abstract][Full Text] [Related]
17. Upregulation of prostaglandin receptor EP1 expression involves its association with cyclooxygenase-2.
Sood R; Flint-Ashtamker G; Borenstein D; Barki-Harrington L
PLoS One; 2014; 9(3):e91018. PubMed ID: 24614038
[TBL] [Abstract][Full Text] [Related]
18. Cyclooxygenase-2 enhances alpha2beta1 integrin expression and cell migration via EP1 dependent signaling pathway in human chondrosarcoma cells.
Liu JF; Fong YC; Chang CS; Huang CY; Chen HT; Yang WH; Hsu CJ; Jeng LB; Chen CY; Tang CH
Mol Cancer; 2010 Feb; 9():43. PubMed ID: 20178602
[TBL] [Abstract][Full Text] [Related]
19. EP1 receptor is involved in prostaglandin E2-induced osteosarcoma growth.
Niu JC; Ma N; Liu W; Wang PJ
Bosn J Basic Med Sci; 2019 Aug; 19(3):265-273. PubMed ID: 30995899
[TBL] [Abstract][Full Text] [Related]
20. Analgesic effects of prostaglandin E2 receptor subtype EP1 receptor antagonist: experimental study of application of nucleus pulposus.
Sekiguchi M; Otoshi K; Kikuchi S; Konno S
Spine (Phila Pa 1976); 2011 Oct; 36(22):1829-34. PubMed ID: 21270690
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
